Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia

Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, Verbee M, Unglaub JM, Thol F, Krause S, Haenel M, Neuerburg C, Vucinic V, Jehn CF, Severmann J, Wass M, Fransecky L, Chemnitz J, Holtick U, Schaefer-Eckart K, Schroeder J, Kraus S, Krueger W, Kaiser U, Scholl S, Koch K, Henning L, Kobbe G, Haas R, Alakel N, Roehnert MA, Sockel K, Hanoun M, Platzbecker U, Holderried TAW, Morgner A, Heuser M, Sauer T, Goetze KS, Wagner-Drouet E, Doehne K, Doehner H, Schliemann C, Schetelig J, Bornhaeuser M, Germing U, Schroeder T, Middeke JM (2021)


Publication Type: Conference contribution

Publication year: 2021

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

DOI: 10.1182/blood-2021-153440

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Rautenberg, C., Stoelzel, F., Roellig, C., Stelljes, M., Gaidzik, V., Lauseker, M.,... Middeke, J.M. (2021). Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia. In BLOOD. WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Rautenberg, Christina, et al. "Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2021.

BibTeX: Download